•¶•”‰ÈŠwÈ‰ÈŠw‹ZplÞˆç¬”ï•â•‹à@ƒ|ƒXƒgƒhƒNƒ^[EƒLƒƒƒŠƒAŠJ”­Ž–‹Æ
_ŒË‘åŠw¶–½ˆãŠwƒCƒmƒx[ƒVƒ‡ƒ“‘noƒŠ[ƒ_[—{¬ƒvƒƒOƒ‰ƒ€

Training Program for The Future Leaders of Innovative Study in biomedical Science


¶–½ˆãŠwƒCƒmƒx[ƒVƒ‡ƒ“‘nolÞ—{¬ƒZƒ“ƒ^[@

ŸƒZƒ“ƒ^[’·Ÿ
_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@“à‰ÈŠwuÀ@Á‰»Ší“à‰ÈŠw•ª–ì
‹³Žö@“Œ@Œ’iTakeshi Azumaj

ŸƒR[ƒfƒBƒl[ƒ^[Ÿ
_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@“à‰ÈŠwuÀ@Á‰»Ší“à‰ÈŠw•ª–ì
“Á–½uŽt@™–{@^Ž÷iMaki Sugimotoj

_ŒË‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@“à‰ÈŠwuÀ@Á‰»Ší“à‰ÈŠw•ª–ì
“Á–½y‹³Žö@—Lâ@DŽjiYoshifumi Arisakaj

Ÿ‰^‰cˆÏˆõ‰ïˆÏˆõ@15–¼Ÿ
Š‘® –ðE Ž–¼
ˆãŠwŒ¤‹†‰È ‹³Žö
ˆÏˆõ’·
“Œ@Œ’
ˆãŠwŒ¤‹†‰È ‹³Žö b‘º@‰p“ñ
ˆãŠwŒ¤‹†‰È ‹³Žö ™‘º˜a˜N
ˆãŠwŒ¤‹†‰È ‹³Žö •½ˆä‚Ý‚Ç‚è
ˆãŠwŒ¤‹†‰È ‹³Žö žÒ—с@—zˆê
ˆãŠwŒ¤‹†‰È “Á–½uŽt ™–{@^Ž÷
ˆãŠwŒ¤‹†‰È y‹³Žö —Lâ@DŽj
•ÛŒ’ŠwŒ¤‹†‰È ‹³Žö ˆÉ“¡@ŒõG
•ÛŒ’ŠwŒ¤‹†‰È ‹³Žö –،ˁ@—Ç–¾
”_ŠwŒ¤‹†‰È ‹³Žö …–ì@‰ëŽj
”_ŠwŒ¤‹†‰È ‹³Žö ‘åàV@˜N
ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È ‹³Žö —…@ŽuˆÌ
ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È ‹³Žö ŠLŒ´@r–ç
ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È ‹³Žö ŒF–{@‰xŽq
HŠwŒ¤‹†‰È ‹³Žö ’Ë–{@¹•F

Ÿ‘IlE—{¬•]‰¿ˆÏˆõ‰ïˆÏˆõŸ
ã‹LˆÏˆõ15–¼@{@ŠO•”•]‰¿ˆÏˆõiŠwŠO—LŽ¯ŽÒj3–¼


ƒvƒƒOƒ‰ƒ€ŽQ‰ÁŽÒ

Ÿ•½¬22”N“xŸ
 Ž–¼ Š‘®^êU  ƒCƒ“ƒ^[ƒ“ƒVƒbƒvæ 
“Ÿ@ŠC›Ù ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È^ŒvŽZ‰ÈŠw (Š”)”ò’¹“d‹@»ìŠ
Ž›“c@—²Æ ‘åã‘åŠwHŠwŒ¤‹†‰È^
—ÊŽqƒGƒlƒ‹ƒM[HŠw
(Š”)ƒ‚ƒŠƒ^»ìŠ
“c’†@S˜a ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw ƒIƒŠƒ“ƒpƒXƒƒfƒBƒJƒ‹ƒVƒXƒeƒ€ƒY(Š”)
‹ß“¡@–õ”V ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  ƒVƒXƒƒbƒNƒX(Š”)
–{é@–L”V ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È^î•ñ’m”\Šw (Š”)”ò’¹“d‹@»ìŠ
Z—F@–¾Žq •ÛŒ’ŠwŒ¤‹†‰È^×–E‹@”\E\‘¢‰ÈŠw (Š”)ƒJƒ“Œ¤‹†Š
¼–؁@M”V  ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw ƒIƒŠƒ“ƒpƒXƒƒfƒBƒJƒ‹ƒVƒXƒeƒ€ƒY(Š”)

Ÿ•½¬23”N“xŸ
 Ž–¼ Š‘®^êU  ƒCƒ“ƒ^[ƒ“ƒVƒbƒvæ 
 r–؁@–]Žk ˆãŠwŒ¤‹†‰È^•ªŽq¶•¨Šw  _ŒË“V‘R•¨‰»Šw(Š”) 
‰–Œ©@—D‹I  ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  (Š”)Á‰»ŠíŒ’Nˆã—ÃTƒ|[ƒg 
 ‘åˆä@[ ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  (Š”)ƒJƒlƒJ 
 “¡“‡@‰À–¢ ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  (Š”)ƒAƒ_ƒ` 
 ‰GŠ±Ši“ú ˆãŠwŒ¤‹†‰È^•ªŽq–ò—E–ò—ƒQƒmƒ€Šw  (Š”)ƒJƒ“Œ¤‹†Š 
 —k@—Ñ ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  (Š”)Á‰»ŠíŒ’Nˆã—ÃTƒ|[ƒg 
 ¬”¨@‘å•ã  ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw (Š”)ƒ‚ƒŠƒ^»ìŠ 

Ÿ•½¬24”N“xŸ
 Ž–¼ Š‘®^êU  ƒCƒ“ƒ^[ƒ“ƒVƒbƒvæ 
²–ì@Œ\Œá ˆãŠwŒ¤‹†‰È^ŒŒŠÇ¶•¨Šw (Š”)ƒJƒ“Œ¤‹†Š
Â„‰Ô ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  (Š”)ƒgƒ‰ƒXƒgƒƒfƒBƒbƒN
ŽR–{@“N–ç HŠwŒ¤‹†‰È^“d‹C“dŽqHŠw ƒ†ƒjƒo(Š”)
¼Œ´@“Õ‹N ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  (Š”)“‡’лìŠ
‘º“c@“Ä ‘ˆî“c‘åŠw—HŠwp‰@^¶–½ˆã‰ÈŠw ƒ{ƒ“‘åŠw‚ÆMiltenyi BiotecŽÐ‚Ì
‹¤“¯ƒ‰ƒ{ƒ‰ƒgƒŠ
‘ºŽR@’¨ ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È^ŒvŽZ‰ÈŠw ƒJƒŠ[ƒiƒVƒXƒeƒ€(Š”)
Šâ–{@²  ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw ƒRƒjƒJƒ~ƒmƒ‹ƒ^
ƒeƒNƒmƒƒW[ƒZƒ“ƒ^[(Š”)

Ÿ•½¬25”N“xŸ
 Ž–¼ Š‘®^êU  ƒCƒ“ƒ^[ƒ“ƒVƒbƒvæ 
ŽR–{@KŽi ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw (Š”)ƒJƒ“Œ¤‹†Š
¬—с@—² ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw  (Š”)“‡’ÃeƒNƒmƒŠƒT[ƒ`
X“c@”Ž”V ”_ŠwŒ¤‹†‰È^ŠÂ‹«E¶‘ÔƒVƒXƒeƒ€HŠw ˆê”ʍà’c–@l“ú–{H•i•ªÍƒZƒ“ƒ^[
•ÐŽR@‘ñ–ç HŠwŒ¤‹†‰È^“d‹C“dŽqHŠw ƒJƒŠ[ƒiƒVƒXƒeƒ€(Š”)
•Ÿ“ˆ@—tŽq ˆãŠwŒ¤‹†‰È^ŒŒŠÇ¶•¨Šw (Š”)ƒJƒ“Œ¤‹†Š

Ÿ•½¬26”N“xŸ
 Ž–¼ Š‘®^êU  ƒCƒ“ƒ^[ƒ“ƒVƒbƒvæ 
‚¼@—˜Š° ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw (Š”)“¡»ìŠ
ŒÓ@³^ ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È^ŒvŽZ‰ÈŠw  ƒAƒgƒi[ƒv(Š”)
Šâ–{@“TŽq ˆãŠwŒ¤‹†‰È^×–E¶•¨Šw (Š”)ƒJƒ“Œ¤‹†Š
ì–ì@—C‹P ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw (Š”)Á‰»ŠíŒ’Nˆã—ÃTƒ|[ƒg
‹g’†@—El ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw “Á’è”ñ‰c—˜Šˆ“®–@lÁ‰»ŠíŒ’Nˆã—ÃŒ¤‹†‹@\
Ž{@ƒC ƒVƒXƒeƒ€î•ñŠwŒ¤‹†‰È^ŒvŽZ‰ÈŠw (Š”)ƒvƒƒAƒVƒXƒg
’@—Ñ —ŠwŒ¤‹†‰È^¶•¨Šw ŠÖ¼‰»H(Š”)
–쑺@—Y‘å ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw (Š”)“¡»ìŠ
‘é”ö@r’B ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw (Š”)Á‰»ŠíŒ’Nˆã—ÃTƒ|[ƒg
‘é”ö@‚܂ljÀ ˆãŠwŒ¤‹†‰È^Á‰»Ší“à‰ÈŠw (Š”)Á‰»ŠíŒ’Nˆã—ÃTƒ|[ƒg